Dr. Edith Perez is a professor of medicine at the Mayo Clinic in Jacksonville, FL, and the co-principal investigator and North American coordinator for the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) clinical trial, an international phase III clinical trial that aims to define the optimal treatment for early stage HER2-positive breast cancer.

The National Cancer Institute asked several questions related to her clinical trial on ALTTO.

See Q&A here.

Tags: Add new tag, ALTTO, Breast Cancer, Breast Cancer, Cancer, Edith Perez, Jacksonville, Mayo Clinic Jacksonville, MCJ